Subscriptions

Advertising

Resources

About Us

Contact Us

Create An Account Forgot Your Password?
Trouble logging in or creating an account? click here
Home This Month E-Weekly Newsletter Building a Facility Article Archive Second Opinions
Search:
Benchmarking
General Surgery
Accrediting/Quality
Anesthesia
Code/Bill/Reimburse
Building/Renovating
/_media/adv/web/images/2011/20111226_Soma_LB-154x100.gif
/_media/adv/web/images/2011/20111202_Arthrex_LB-154x100.jpg
/_media/adv/web/images/2012/20120126_ASP_LB-154x100.gif
/_media/adv/web/images/2012/20120123_PDI_LB-154x100.gif
Outpatient Surgery E-Weekly

Contact Congress Over Drug Shortage Issues

A Kentucky congressman is urging surgical facilities to contact their members of Congress and request that they sign his letter demanding changes to...

N.J. Posts ASC Inspection Reports Online

State and federal inspection reports of New Jersey's ASCs are now available online, giving patients an opportunity to make more informed choices abo...

Are Opioids Necessary?

While it's not always practical, or even possible, to eliminate opioids from your post-op pain management regiment, reducing their use in favor of n...

Home > News > October, 2009

Care-Tech Laboratories Suspends Operations Amid FDA Probe

St. Louis-based company agrees to stop making, selling and distributing unnapproved antimicrobial products.

Published: October 14, 2009
Categories: Product Reports, News

Care-Tech Laboratories, makers of Techni-Care pre-operative prep solutions and surgical scrub and several other over-the-counter antimicrobial drugs used to treat and prevent infection, has signed a consent decree, agreeing to stop the illegal manufacture, marketing and distribution of its products, says the U.S. Food and Drug Administration.

FDA inspectors found that Care-Tech violated numerous provisions of the FDA's current good manufacturing practice (cGMP) regulations that direct how antimicrobial drugs are made. Additionally, the products do not conform to any applicable regulations for OTC drug products and have not undergone an FDA review, and therefore are considered unapproved drug products.

Under the terms of the consent decree, Care-Tech may not resume manufacturing and distribution of the drugs until it corrects these and other violations. Neither FDA nor Care-Tech is aware of any reports of injury or illness related to the use of these products, and FDA has not issued a product recall. "The company is committed to ensuring that each of its products reflects the highest standards of safety and purity," says John C. Brereton, the president of Care-Tech.

Dan O'Connor

© Copyright Herrin Publishing Partners LP 2011. REPRODUCTION OF THIS COPYRIGHTED CONTENT IS STRICTLY PROHIBITED. We encourage LINKING to this content; view our linking policy here.


Also in the News...

6 Tips for a Stress-Free Accreditation Survey

Are You Ready for an MH Emergency?

Just How Useful (Really) Is Gowning and Gloving?

Despite Huge Return on Their Investment, 3 Retinal Surgeons Squeezed Out of ASC Sue

14 Hospitals Pay $12M to Settle Medicare Fraud Charges Surrounding Spinal Surgery Billing

Could Your Facility Use a Spark?

Did Hospital Settle Malpractice Case to Spite Its Chief of Surgery?

© Copyright Herrin Publishing Partners LP 2011. REPRODUCTION OF THIS COPYRIGHTED CONTENT IS STRICTLY PROHIBITED. We encourage LINKING to this content; view our linking policy here.

Already have an account? Please sign in:
Email Address:
Password:
PRODUCT & SERVICE RESOURCES
Did You See This?
A showcase of products and services geared to make your facility better.

Architects' Showcase
Is a beautiful, efficient new facility in your future?
/_media/adv/web/images/2011/20111111_CareFusion_AR-300x250.jpg
Other Articles That May Interest You
Who Was to Blame for the Botched Malpractice Settlement?
Implosion of last-minute $150K deal opens door to $1M verdict.
Hospital Strips Disruptive Surgeon of Privileges for a Year
Minn. ortho surgeon temporarily sidelined after losing appeal.
NFL Team Doc Ordered to Pay $2.2M for Botched Hip Surgery
Arbitration panel finds surgeon negligent in surgery that left woman with permanent damage to leg.